Massive treatment of Ebola continues in DR Congo

A second Ebola vaccine is to be offered to around 50,000 people in the Democratic Republic of Congo as part of a major clinical trial.

The vaccine will be used with the directive of the presidency which has already been given to around 250,000 people.

A pharmaceutical Merck’s Jab has now been approved by the World Health Organization to handle project.

More than 2,100 people have died in DR Congo, in the second largest ebola outbreak on record. The WHO’s approval of Merck’s one-dose vaccine is based on it being satisfied of its safety and efficacy.